Frost & Frost Gamma Update BioCardia Stake
Ticker: BCDA · Form: SC 13D/A · Filed: Apr 5, 2024 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | SC 13D/A |
| Filed Date | Apr 5, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.40, $0.59, $0.50, $0.55, $0.53 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, schedule-13d, ownership-change
Related Tickers: BCDA
TL;DR
Frost & Frost Gamma just updated their BioCardia filing. Watch this space.
AI Summary
Phillip Frost, M.D. and Frost Gamma Investments Trust have amended their Schedule 13D filing for BioCardia, Inc. on April 5, 2024. This filing indicates a change in their beneficial ownership of the company's common stock. The specific details of the change in ownership percentage or number of shares are not explicitly stated in this excerpt, but it signifies an update to their holdings.
Why It Matters
Changes in significant shareholder filings like this can signal shifts in control or influence, potentially impacting the stock price and future strategic direction of BioCardia, Inc.
Risk Assessment
Risk Level: medium — Schedule 13D filings by significant shareholders like Phillip Frost can indicate potential activism or changes in investment strategy, which may lead to stock price volatility.
Key Players & Entities
- Phillip Frost, M.D. (person) — Filing party
- Frost Gamma Investments Trust (company) — Filing party
- BioCardia, Inc. (company) — Subject company
FAQ
What is the specific change in beneficial ownership reported in this amendment?
This excerpt does not specify the exact change in beneficial ownership percentage or number of shares, only that an amendment was filed on April 5, 2024.
Who are the primary filers of this Schedule 13D/A?
The primary filers are Phillip Frost, M.D. and Frost Gamma Investments Trust.
What is the subject company of this filing?
The subject company is BioCardia, Inc.
When was this amendment filed with the SEC?
This amendment was filed on April 5, 2024.
What is the SIC code for BioCardia, Inc.?
The SIC code for BioCardia, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 1,592 words · 6 min read · ~5 pages · Grade level 6.8 · Accepted 2024-04-05 16:13:08
Key Financial Figures
- $0.40 — multiple trades at prices ranging from $0.40 to $0.59 in the open market as describe
- $0.59 — trades at prices ranging from $0.40 to $0.59 in the open market as described in the
- $0.50 — rice Range February 28, 2024 20,000 $0.50 - $0.55 February 29, 2024 20,000 $0
- $0.55 — ge February 28, 2024 20,000 $0.50 - $0.55 February 29, 2024 20,000 $0.53 - $0
- $0.53 — 50 - $0.55 February 29, 2024 20,000 $0.53 - $0.56 March 1, 2024 20,000 $0.54
- $0.56 M — 55 February 29, 2024 20,000 $0.53 - $0.56 March 1, 2024 20,000 $0.54 - $0.58 Ma
- $0.54 — $0.53 - $0.56 March 1, 2024 20,000 $0.54 - $0.58 March 4, 2024 20,000 $0.42
- $0.58 M — $0.56 March 1, 2024 20,000 $0.54 - $0.58 March 4, 2024 20,000 $0.42 - $0.59 Ma
- $0.42 — $0.54 - $0.58 March 4, 2024 20,000 $0.42 - $0.59 March 5, 2024 20,000 $0.41
- $0.59 M — $0.58 March 4, 2024 20,000 $0.42 - $0.59 March 5, 2024 20,000 $0.41 - $0.46 Ma
- $0.41 — $0.42 - $0.59 March 5, 2024 20,000 $0.41 - $0.46 March 6, 2024 20,000 $0.41
- $0.46 M — $0.59 March 5, 2024 20,000 $0.41 - $0.46 March 6, 2024 20,000 $0.41 - $0.45 Ma
- $0.45 M — $0.46 March 6, 2024 20,000 $0.41 - $0.45 March 7, 2024 20,000 $0.41 - $0.43 Ma
- $0.43 M — $0.45 March 7, 2024 20,000 $0.41 - $0.43 March 8, 2024 20,000 $0.41 - $0.44 Ma
- $0.44 M — $0.43 March 8, 2024 20,000 $0.41 - $0.44 March 11, 2024 20,000 $0.41 - $0.44 M
Filing Documents
- tm2411035d1_sc13da.htm (SC 13D/A) — 60KB
- tm2411035d1_ex1.htm (EX-99.1) — 4KB
- 0001104659-24-044271.txt ( ) — 66KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct. Date: April 5, 2024 Dr. Phillip Frost By: /s/ Phillip Frost, M.D. Frost Gamma Investments Trust By: /s/ Phillip Frost, M.D. Phillip Frost, M.D. Trustee